Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: drdan who wrote (4410)	10/19/1998 2:05:00 PM
From: Jim B	Read Replies (1) \| Respond to of 5402

well, I would think that if a medical reason exists for a PFC to be done on an individual then most likely the athletic community wouldn't able to disallow those people to participate in professional or amateur sports... if PHER-02 becomes the product many think it will, we may just see the surgeon general recommending it in some form or fashion to any and all who would like to increase the efficiency of their bodies.. might take 10years for that to happen.. but who knows... I don't believe that clotting is really going to be a concern for the doctor because of the molecular and cell size ... I don't remember the specifics.. maybe prospector can comment.. but I remember reading that "clotting" shouldn't be an issue because of PHER02's design. jim